November 01, 2025
The simulators market size is projected to expand from USD 14.72 billion in 2026 to USD 25.53 billion by 2034,...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 26, 2025
The U.S. behavioral health market is anticipated to grow from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 27, 2025
According to market projections, the vaccine adjuvant sector is expected to grow from USD 747.6 million in 2025 to USD 1394.15 million by 2035, reflecting a CAGR of 6.43%.The market is growing due to rising demand for stronger and longer-lasting immune responses....
November 27, 2025
Projections indicate that, precision medicine industry is projected to rise from USD 118.52 billion in 2025 to USD 538.83 billion by 2035, reflecting a CAGR of 16.35% over the next decade. The market is growing due to increasing demand for personalized treatments tailored to individual genetic profiles. Advancements in genomics and data analytics a...
November 27, 2025
Projections indicate that, the global diabetic neuropathy treatment market will increase from USD 4.71 billion in 2024 to USD 9.93 billion by 2034, experiencing a CAGR of 7.75% over the next 10 years. The diabetic neuropathy treatment market is expanding due to increasing incidences of diabetes as well as rising gene therapies. North America led th...
November 26, 2025
According to market projections, the global modified antibody market, valued at USD 3.10 billion in 2025, is anticipated to reach USD 7.36 billion by 2035, growing at a CAGR of 9.04% over the next decade. The biopharmaceutical contract manufacturing market is growing rapidly, fueled by rising outsourcing and biologics demand. The report includes ...
November 26, 2025
Market insights predict the global asthma and COPD medicines industry will increase from USD 13.10 billion in 2025 to USD 19.32 billion by 2035, achieving a CAGR of 3.96%. The asthma and COPD medicines market is growing due to the increasing prevalence of these diseases, driven by smoking and pollution, and an increasing and aging worldwide populat...
November 26, 2025
Market insights predict the global probiotic industry will increase from USD 114.31 billion in 2025 to USD 429.01 billion by 2035, achieving a CAGR of 14.14%. The probiotics market is growing due to growing awareness about gut health. Asia Pacific is leading the market due to a large consumer base....
November 26, 2025
According to market projections, the global over-the-counter or OTC drugs market, valued at USD 142.27 billion in 2025, is anticipated to reach USD 268.32 billion by 2035, growing at a CAGR of 6.55% over the next decade. In 2024, North America led the OTC drugs market, while Asia-Pacific is set for rapid growth. Cough & cold products dominated,...
November 25, 2025
According to forecasts, the global hemorrhoids treatment market will grow from USD 1.21 billion in 2025 to USD 2.18 billion by 2035, with an expected CAGR of 6.05%. The rising incidence of hemorrhoids and the increasing minimally invasive procedures drive the market. North America dominated the global market due to a robust healthcare infrastructur...
November 25, 2025
According to forecasts, the global antithrombin market will grow from USD 420.33 million in 2025 to USD 640.37 million by 2035, with an expected CAGR of 4.3%. The antithrombin market is driven by technological advancements across the various steps involved in its production. North America is leading the market due to the strong presence of the phar...
November 25, 2025
According to market projections, the monoclonal antibody for asthma and COPD sector is expected to grow from USD 34.02 billion in 2025 to USD 58.94 billion by 2035, reflecting a CAGR of 5.65%, providing detailed analysis of disease-specific segments, regional distribution (NA, EU, APAC, LA, MEA), manufacturer data, competitive benchmarking, value...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com